MK5, also known as MAPKAPK5, has recently been shown to be a positive regulator of YAP in both mesothelioma and uveal melanoma, by its association with YAP preventing CK1δ/ε-mediated proteasomal degradation. The gene discussed is YAP1; the disease is mesothelioma.